💊 Fisetin Cancer Research

Fisetin is a naturally occurring flavonoid compound found in various fruits and vegetables that has attracted significant attention from cancer researchers in recent years. As a senolytic agent—a substance that selectively eliminates senescent cells—fisetin represents a novel approach to cancer treatment that differs from traditional chemotherapy. Senescent cells are aging cells that can accumulate in tumors and contribute to cancer progression, chemotherapy resistance, and tumor microenvironment changes that support cancer growth. By targeting and removing these problematic cells, fisetin may help reduce tumor burden and improve treatment outcomes.

The current state of fisetin research for cancer is still largely in preclinical and early clinical stages. Laboratory studies have demonstrated promising anti-cancer properties, including the ability to trigger apoptosis (programmed cell death) in cancer cells and inhibit tumor growth in animal models. Researchers are particularly interested in fisetin's potential to work synergistically with existing cancer therapies and its favorable safety profile as a naturally-derived compound. However, more clinical trials are needed to establish its efficacy and optimal dosing in human cancer patients.

This page compiles the latest peer-reviewed research on fisetin and cancer to help patients, caregivers, and healthcare providers stay informed about emerging evidence. While the findings are encouraging, it's important to note that fisetin should not replace conventional cancer treatments without medical consultation. The articles and studies featured below represent the most current scientific investigations into fisetin's role in cancer research and treatment.